B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

quizartinib-resistant FLT3 mutants

REACTOME PATHWAY
Reactome: R-HSA-97026201 genes14 compounds

The quizartinib-resistant FLT3 mutants pathway (Reactome ID: R-HSA-9702620) involves 1 genes and is affected by 14 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

FLT3

Compounds Affecting quizartinib-resistant FLT3 mutants

#CompoundTargets HitStudies
1Sorafenib300
2Axitinib298
3Crizotinib298
4pictilisib25
5Afatinib297
6tyrphostin ag 12951
7Apigenin 5,7,4'-trihydroxy-flavone,300
8Kaempferols300
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
10myricetin-3-O-galactopyranoside [Supplementary Concept]300
11Quercetin300
12kenpaullone8
13sp600125117
14tyrphostin ag 14784

About the quizartinib-resistant FLT3 mutants Pathway

The quizartinib-resistant FLT3 mutants pathway is catalogued in Reactome (ID: R-HSA-9702620) and involves 1 genes. In the BiohacksAI corpus, 14 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include FLT3.